Erythromycin Oxime: Your Key to Advanced Antibiotics
Unlock the synthesis of next-generation macrolide antibiotics with our high-purity Erythromycin Oxime.
Get a Quote & SampleProduct Core Value
Erythromycin Oxime
Erythromycin Oxime (CAS 13127-18-9) is a premium pharmaceutical intermediate, essential for the development and large-scale synthesis of crucial second and third-generation macrolide antibiotics. Its high purity and adherence to global quality standards make it indispensable for pharmaceutical manufacturers.
- Discover the synthesis of roxithromycin with this vital pharmaceutical intermediate.
- Secure your supply of azithromycin manufacturing raw material, ensuring consistent quality.
- Facilitate clarithromycin synthesis by utilizing a reliably sourced chemical.
- Explore the dirithromycin production intermediate that meets rigorous industry demands.
Product Advantages
Uncompromised Purity
Attain a 99.5% minimum assay, crucial for sensitive pharmaceutical processes and ensuring the efficacy of your final antibiotic product when you buy Erythromycin Oxime 13127-18-9.
Global Quality Compliance
Our Erythromycin Oxime adheres to USP, BP, EP, and FCC standards, providing confidence in its suitability for diverse pharmaceutical applications and regulatory requirements.
Cost-Effective Synthesis
Benefit from competitive pricing on this essential Erythromycin Oxime 99.5% min assay, making your advanced macrolide antibiotic production more economically viable.
Key Applications
Roxithromycin Synthesis
Leverage Erythromycin Oxime as a critical building block for the efficient and high-yield synthesis of roxithromycin, a widely used antibiotic.
Azithromycin Production
Utilize this high-purity intermediate for the manufacturing of azithromycin, an essential drug for treating various bacterial infections.
Clarithromycin Manufacturing
Ensure the quality of your clarithromycin by employing Erythromycin Oxime, a foundational component in its complex chemical synthesis pathway.
Dirithromycin Development
Support the development and production of dirithromycin with this reliable pharmaceutical intermediate, contributing to broader antibiotic options.